Class II

Drug Recall: Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wale

Teva Pharmaceuticals USA, Inc · March 7, 2024

Reason for Recall

Failed Dissolution Specifications

Product Description

Tri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in carton containing 3 Blister Cards, 28 Tablets Each, Rx only, Teva Pharmaceuticals USA, INC, North Wales, PA 19454, NDC 0093-2140-62

Distribution

USA nationwide.

States Affected

NATIONWIDE

Quantity Affected

92,676 cartons

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0428-2024

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.